DIANA LOSAK: Open Payments
NPI 1598008690 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,885 in 131 payments from 20 companies in 2025. Trend: 2023 $2,771 · 2024 $2,480 · 2025 $2,885
Food & beverage: $2,885
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 12 | $417 |
| GENZYME CORPORATION | 10 | $331 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $304 |
| Novartis Pharmaceuticals Corporation | 10 | $222 |
| Arcutis Biotherapeutics, Inc. | 15 | $218 |
| Galderma Laboratories, L.P. | 8 | $189 |
| ABBVIE INC. | 12 | $161 |
| Janssen Biotech, Inc. | 6 | $139 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $128 |
| Lilly USA, LLC | 6 | $126 |
Products named: DUPIXENT, ADBRY, Zoryve, ILUMYA, NEMLUVIO, TREMFYA, COSENTYX, ANZUPGO.
Industry payments across TX — which companies pay providers there.
